Can H. Pylori Cause Shortness of Breath?

H. pylori does not directly attack the lungs, but the infection can cause shortness of breath through several indirect routes, most commonly by triggering anemia that starves the body of oxygen-carrying capacity. A published case report documents a 44-year-old man who presented with breathlessness as a primary complaint and was ultimately diagnosed with vitamin B12 deficiency caused by H. pylori gastritis. That case is far from unique. The bacterium’s effects ripple outward from the stomach in ways that involve iron absorption, low-grade systemic inflammation, and even cardiovascular damage, all of which can leave you feeling winded.

Anemia as a Hidden Cause of Breathlessness

The most straightforward path from an H. pylori infection to shortness of breath runs through anemia. When your red blood cell count or hemoglobin drops below normal, your tissues receive less oxygen per heartbeat, and your body compensates by breathing harder and faster. Two forms of anemia are connected to H. pylori: iron deficiency anemia and vitamin B12 deficiency anemia.

Iron is absorbed primarily in the duodenum, the first stretch of the small intestine, and the process depends on stomach acid and certain transport proteins. H. pylori causes chronic inflammation in the stomach lining, which suppresses acid production and interferes with the proteins that shuttle iron into the bloodstream.¹ Over months or years, this can quietly drain your iron stores. A report on three adolescents with severe iron-deficiency anemia found that all three had H. pylori gastritis and that their anemia had resisted standard iron supplements. Only after the infection was eradicated did their iron levels recover.²

The vitamin B12 pathway works similarly but involves a different mechanism. H. pylori gastritis can damage the cells that produce intrinsic factor, a protein your gut needs to absorb B12. Without enough B12, your bone marrow makes abnormally large, dysfunctional red blood cells, a condition called megaloblastic anemia. The published case of the 44-year-old man is a textbook example: he arrived at the hospital short of breath and fatigued, with numbness in his hands and feet, and the root cause turned out to be B12 deficiency driven entirely by H. pylori infection in his stomach.³

What makes both of these scenarios tricky is that you might not connect the dots. Shortness of breath, fatigue, and pale skin look like a hundred different things. If your doctor tests for anemia but does not investigate H. pylori as the underlying cause, iron or B12 supplementation alone may fail to fix the problem because the bacterium keeps sabotaging absorption.

Airway Inflammation You Cannot Feel

Beyond anemia, H. pylori appears to stoke low-grade inflammation that reaches the airways even when the lungs themselves are not infected. A study that analyzed exhaled breath condensate from H. pylori-positive patients found elevated levels of two inflammatory markers, 8-isoprostane and interleukin-6, compared to uninfected controls. The researchers described it as “asymptomatic airway inflammation,” meaning the patients did not report coughing or wheezing, yet measurable inflammation was present in their airways.⁴

The clinical significance of that finding is still debated. Detectable inflammation does not automatically mean you will feel breathless, and the study’s authors acknowledged that the real-world impact remained unclear. But it does suggest a plausible biological mechanism: chronic infection in the gut generates inflammatory signals that circulate through the bloodstream and provoke a response in distant tissues, including the lungs. For someone who already has mild lung compromise from another cause, even a subtle inflammatory burden could tip the balance toward noticeable breathing difficulty.

Links to Chronic Lung Disease

Several studies have explored whether H. pylori infection is more common in people with chronic obstructive pulmonary disease. A meta-analysis and Mendelian randomization study found that patients with severe-to-very-severe COPD had a higher prevalence of H. pylori infection than those with milder disease.⁵ That association raises the question of whether the infection worsens lung decline or whether people with advanced COPD simply have more opportunity to acquire H. pylori through factors like repeated hospitalizations and antibiotic exposure.

Not every study agrees. A separate investigation that used both blood antibody tests and PCR on lung fluid samples found no statistically significant relationship between H. pylori presence and COPD severity.⁶ A broader literature review concluded that H. pylori might play a role in chronic bronchitis and bronchiectasis, though the evidence for a direct causal link remains mixed.⁷

Separately, H. pylori has been associated with weakened pulmonary function and chronic cough. In one study, about two-thirds of patients with chronic cough that had resisted other treatments saw significant improvement after successful H. pylori eradication.⁸ If you have been dealing with a persistent cough and diminished lung function that no one can explain, an untreated H. pylori infection is at least worth investigating.

Cardiovascular Damage and Exertional Breathlessness

Shortness of breath during physical activity is one of the hallmark symptoms of coronary artery disease, and H. pylori has been linked to ischemic heart disease through a specific mechanism involving the bacterium’s more aggressive strains. Research has focused on strains carrying the CagA gene, a virulence factor that provokes a stronger inflammatory response. In one case-control study, patients with ischemic heart disease were significantly more likely to carry CagA-positive strains than matched controls. The adjusted odds of heart disease were nearly four times higher in people infected with CagA-positive H. pylori compared to uninfected individuals.⁹ CagA-negative strains, by contrast, showed no increased risk.

A follow-up study reinforced this distinction. Among patients with confirmed heart disease, those carrying CagA-positive strains showed worse exercise-induced changes on electrocardiograms compared to uninfected patients, suggesting more severe coronary vessel damage.¹⁰ The proposed explanation is that persistent, low-grade inflammation from a virulent H. pylori infection accelerates atherosclerosis, the buildup of fatty plaques in coronary arteries. When those arteries narrow enough, the heart cannot pump adequate blood during exertion, and breathlessness follows.

This does not mean H. pylori alone will give you heart disease. Smoking, high blood pressure, diabetes, and cholesterol levels are far more established risk factors. But for someone who already carries some cardiovascular risk, a chronic CagA-positive infection could be one more contributor nudging the process along. The connection between gut infection and coronary inflammation is still an active area of research, and it is worth noting that some studies in different populations have not replicated the same strength of association.

What Eradication Resolves

The good news for people whose breathing trouble traces back to H. pylori is that treating the infection often leads to improvement. The anemia cases are the most clear-cut. When iron-deficiency anemia resists oral iron supplements, eradicating H. pylori has allowed iron levels to recover in reported cases, presumably because stomach acid production and iron-transporting proteins begin to function normally again.² The same logic applies to B12 deficiency: once the gastritis heals, intrinsic factor production can rebound, and supplementation becomes effective.

For respiratory symptoms, the evidence is more mixed but still encouraging. The study on chronic refractory cough found that roughly two-thirds of patients improved after H. pylori eradication therapy.⁸ Whether the improvement came from reduced airway inflammation, resolution of subclinical reflux, or some other mechanism is not entirely settled. But from a practical standpoint, if you have a cough or breathing difficulty that has defied diagnosis and you test positive for H. pylori, eradication therapy is a relatively low-risk intervention that might solve the mystery.

Cardiovascular benefits from eradication are harder to pin down. Clearing the infection should, in theory, reduce the chronic inflammatory stimulus linked to atherosclerosis. But coronary artery disease develops over decades and involves many factors. You would not expect to feel less breathless on a staircase two weeks after finishing antibiotics. The potential benefit here is longer-term and harder to measure in individual patients.

The Counterintuitive Asthma Connection

One of the stranger findings in this research area is that H. pylori infection appears to protect against allergic asthma rather than cause it. A meta-analysis covering more than 17,000 children found that H. pylori-infected kids had a significantly lower risk of developing asthma. The effect was even stronger in children carrying the more virulent CagA-positive strains.¹¹ In one cohort, none of the children infected with H. pylori at age two went on to develop asthma by age sixteen, compared to sixteen percent of those who were never infected.

The proposed explanation involves how the immune system develops. Early exposure to H. pylori may steer the immune system toward responses that tamp down allergic pathways.¹² This fits into a broader pattern in which the declining prevalence of certain old infections in wealthy countries has coincided with rising rates of allergic diseases, including asthma.¹³ Researchers have pointed to a specific H. pylori protein that boosts the production of interferon-gamma while suppressing the interleukin-4 that drives allergic inflammation.¹¹

Not every study confirms this inverse relationship. A large study of young British adults found no association between H. pylori infection and wheeze or hay fever.¹⁴ And the earlier literature review on H. pylori and respiratory disease concluded that the bacterium did not appear to play a role in asthma development.⁷ So the protective effect, if it is real, is probably limited to allergic asthma in children and may depend on genetics, strain virulence, and the timing of exposure. For someone asking “is my H. pylori making me wheeze?”, the answer is almost certainly no: H. pylori either has no effect on asthma or, paradoxically, makes it less likely.

When the Treatment Itself Triggers Breathing Problems

An ironic twist in this whole story is that the antibiotics used to kill H. pylori can occasionally cause their own respiratory side effects. A case series documented six patients who developed pulmonary hypersensitivity during standard eradication therapy. Their symptoms, which included cough, breathlessness, and characteristic changes on chest CT scans, typically appeared seven to twelve days into treatment. All six recovered within about a week after the antibiotics were stopped, and their lung imaging normalized within four weeks.¹⁵

This is rare enough that it should not discourage anyone from treating a confirmed H. pylori infection. Standard triple or quadruple therapy regimens are generally well tolerated, and the risk of leaving the infection untreated, including ulcers, anemia, and a small increase in stomach cancer risk over time, outweighs the chance of a drug reaction. But if you develop new breathing difficulty in the second week of H. pylori treatment, it is worth mentioning to your doctor rather than pushing through. The reaction resolves quickly once the offending drug is identified and stopped, and your doctor can usually switch to a different regimen to finish clearing the infection.